Functionally, neoadjuvant chemotherapy induces proinflammatory cytokines and decreases pro-tumor cytokines from tumor-infiltrating T cells, with enhanced TNF-α and IL-2 and reduced IL-4 and IL-10 expression [10]. The gene discussed is IL2; the disease is neoplasm.